| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.7 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.6 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.26 | 0.1 |